Two recent papers, one in Science and one in Biological Psychiatry, suggest some new ways to look at migraine biology.The Science study followed 237 free-ranging rhesus macaques on Cayo Santiago, the famous "Monkey Island" off Puerto Rico, from birth into adulthood. Researchers paired detailed records of each animal's early life experiences with DNA methylation data from 12 different adult tissues. DNA methylation is one of the main epigenetic marks we use to build so-called "epigenetic clocks", tools that estimate biological age from molecular data. These clocks predicted chronological age to within about a year.They found that aging does not unfold the same way throughout the body. The thymus and pituitary showed particularly strong age-related methylation patterns; blood, the tissue most commonly sampled in human studies, captured only part of the picture.The more striking finding involved early adversity. Maternal loss, low maternal rank, and crowded social conditions each left distinct methylation signatures in adulthood, and these signatures appeared simultaneously across multiple tissues. Thousands of genomic regions were affected, many overlapping with sites that normally change with aging, but the direction of change was inconsistent. Sometimes adversity-related changes looked like accelerated aging; sometimes they went the other way.The Biological Psychiatry paper takes a different angle. In 143 trauma-exposed adults, investigators used a live-cell mitochondrial stress test to measure actual bioenergetic function. Cumulative early adversity correlated with altered mitochondrial respiration, but the pattern depended on the type of trauma. Threat-based trauma (abuse, violence) was linked to lower cellular energy demand and reduced glycolysis. Deprivation-based trauma (neglect, food insecurity) was associated with higher glycolytic activity but less efficient energy production. Two distinct forms of early stress, two distinct metabolic signatures in adult cells.Trauma is common in chronic migraine and pain population. Depending on the study, 40 to 60 percent of chronic migraine and chronic pain patients report a history of significant traumatic experience.We know that roughly a third of migraine patients have reduced CoQ10 levels, and that riboflavin status is often suboptimal, particularly in those with frequent attacks. Both are central to mitochondrial ATP production. The standard explanation has been that these deficits are largely genetic. These two papers raise another possibility.If early adversity can install coordinated epigenetic changes across many tissues and can alter mitochondrial bioenergetics decades later, then at least some of the CoQ10 and riboflavin insufficiency we see in migraine patients may have epigenetic roots.Given how common a trauma history is in this population, integrating trauma history, epigenetic markers, and mitochondrial assays into migraine research seems like a good next step.One practical step we’ve been taking for years at the New York Headache Center is to check CoQ10 and riboflavin levels in all migraine patients, along with tests for RBC magnesium, vitamin B12, vitamin B1 (thiamine), and vitamin D.
